Sarbajit Mukherjee: New Study Reveals Global and Gender Gaps in Oncology Research Authorship
Sarbajit Mukherjee/ baptisthealth.net

Sarbajit Mukherjee: New Study Reveals Global and Gender Gaps in Oncology Research Authorship

Sarbajit Mukherjee, Chief of GI Medical Oncology at Miami Cancer Institute and Co-Chair of GI Clinical Trial Working Group at Hoosier Cancer Research Network, shared on LinkedIn:

“From ASCO presentation to publication!

Our study of global authorship in phase III solid-tumor trials, an extension of our oral presentation at ASCO 2026, was just published in JCO Oncology Practice.

Across 1,517 ASCO abstracts from 2015 – 2025, we found three patterns:

  • Geography: Nearly 85% of abstracts had a senior author based in a high-income country. Only 1.7% had a senior author based in a lower-middle-income country.
  • Authorship trends: Female investigators held 27.9% of first- and senior-author positions. Female senior authorship rose from 21.2% in 2015–2020 to 28.0% in 2021–2025.
  • Tumor type and funding: Adjusted odds of female authorship were lower in GI, GU, and lung cancer trials than in breast cancer trials. Funding source showed no independent association with female authorship.

Special thanks to Dr. Azza Sarfraz, our postdoctoral fellow, for leading this project, and to our coauthors, the Florida International University students who contributed, and everyone who supported this work.”

Title: Global Authorship Patterns in Phase III Solid-Tumor Trials Presented at the ASCO Annual Meeting, 2015-2025

Authors: Azza Sarfraz, Lydia C. Hodgson, Sarah Marie Abraham, Shree Rath, Sawyer Bawek, Kyaw Lwin Aung, Manmeet Singh Ahluwalia, Beas Siromoni, Sarbajit Mukherjee

Read the full article. 

You can also read: